The traditional view holds that the natural course of cirrhosis is a unidirectional process, characterized by irreversible progression from the compensated stage to the decompensated stage, and is highly likely to develop further decompensation events or even death. However, a growing body of evidence suggests that the natural course of cirrhosis is not always unidirectional - after the removal of the etiology, the structural and functional changes of the liver may be partially reversed. This understanding has given rise to the concept of "liver recompensation," which has been standardized at the Baveno VII Consensus Conference. Notably, in a cohort of patients with alcohol-related cirrhosis, 18% achieved recompensation, which was significantly associated with a reduction of more than 90% in liver-related mortality. In patients with hepatitis B-related cirrhosis, 6% achieved recompensation after treatment with nucleos(t)ide analogs, with a similar improvement in mortality. Transjugular intrahepatic portosystemic shunt (TIPS) is a well-established therapy for complications related to portal hypertension, including gastroesophageal variceal bleeding, refractory ascites, and hepatic hydrothorax. Compared with standard treatment, TIPS has been proven to reduce the incidence of further decompensation and improve transplant-free survival. However, due to portal blood shunting, the risks of abnormal liver function and hepatic encephalopathy (HE) also increase. It is worth noting that TIPS is not included in the definition of recompensation in the Baveno VII Consensus. Therefore, whether patients with cirrhosis who undergo TIPS treatment can achieve recompensation and which factors determine the probability of recompensation remain unknown. More importantly, the impact of recompensation on the risk of HCC development and mortality in TIPS patients has not been studied prospectively.
Study Type
OBSERVATIONAL
Enrollment
250
Second Xiangya Hospital, Central South University
Changsha, China
RECRUITINGThe Third Xiangya Hospital of Central South University
Changsha, China
RECRUITINGFujian Medical University Union Hospital
Fuzhou, China
RECRUITINGHuanggang Central Hospital
Huanggang, China
RECRUITINGJingzhou Central Hospital
Jingzhou, China
RECRUITINGJiangxi Provincial People's Hospital
Nanchang, China
RECRUITINGThe First Affiliated Hospital of Nanjing Medical University
Nanjing, China
RECRUITINGShengjing Hospital of China Medical University
Shenyang, China
RECRUITINGShanxi Provincial People's Hospital
Taiyuan, China
RECRUITINGRenmin Hospital of Wuhan University
Wuhan, China
RECRUITING...and 5 more locations
1-year post-TIPS recompensation rate
It refers to the proportion of patients who meet the standardized recompensation criteria (etiology cure, resolution of decompensation events and sustained improvement of liver function) at 12 months after TIPS.
Time frame: 1 year
Identification of factors associated with recompensation at 1 year after TIPS
It refers to the screening and confirmation of potential factors that may affect whether patients achieve recompensation at 1 year after TIPS. Cox Univariate analysis and multivariate regression analysis will be used to identify independent factors associated with recompensation, providing a basis for individualized intervention strategies to improve the recompensation rate of TIPS patients.
Time frame: 1 year
Impact of recompensation on the risk of hepatocellular carcinoma (HCC) development
It refers to the comparison of the incidence of HCC between the recompensation group and the non-recompensation group during the follow-up period after TIPS surgery.
Time frame: 1 year
Impact of recompensation after Transjugular Intrahepatic Portosystemic Shunt on patients' risk of death
At 12 months after Transjugular Intrahepatic Portosystemic Shunt (TIPS), patients were divided into the recompensation group and the non-recompensation group based on whether they met the recompensation criteria, and the Log-rank test was used to analyze the differences in survival outcomes between the two groups.
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.